Delivery Order SPE2DB24D2205-SPE2DB24FDYJS
Award Date
8/13/24
Potential Completion Date
8/14/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The firm-fixed-price delivery order, valued at $17,065.51, has an ultimate completion date of August 22, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office division holds this contract, which is a child contract under a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $8,202.62 and is a firm fixed price delivery order that runs through August 2024. No set-aside designation was used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract, valued at $6,353.50, has a firm fixed price and is scheduled for completion by May 22, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,540.37, is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. This is a delivery order contract, with a firm fixed-price pricing type, and an ultimate completion date of December 18, 2024. The contract does not have a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,437.19, is a Firm Fixed Price Delivery Order for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,054.32 delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a prescription medication. The contract has an ultimate completion date of April 24, 2023 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $17,530.84, is a firm fixed price delivery order for the pharmaceutical product REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The contract has a period of performance through March 27, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a leading...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $31,971.06 for the medical product REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The award has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,041.46 firm-fixed-price delivery order is for the supply of the drug Rebif 44 mcg/0.5 mL syringe. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $64,142.21, is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of June 26, 2024 and is a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen holds a significant...